IL139144A0 - Mycobacterial inhibitors - Google Patents

Mycobacterial inhibitors

Info

Publication number
IL139144A0
IL139144A0 IL13914499A IL13914499A IL139144A0 IL 139144 A0 IL139144 A0 IL 139144A0 IL 13914499 A IL13914499 A IL 13914499A IL 13914499 A IL13914499 A IL 13914499A IL 139144 A0 IL139144 A0 IL 139144A0
Authority
IL
Israel
Prior art keywords
mycobacterial
mycobacterial inhibitors
inhibitors
treatment
certain
Prior art date
Application number
IL13914499A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9802118A external-priority patent/SE9802118D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL139144A0 publication Critical patent/IL139144A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035Isoindoles, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/45Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13914499A 1998-05-05 1999-05-03 Mycobacterial inhibitors IL139144A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN969MA1998 1998-05-05
SE9802118A SE9802118D0 (sv) 1998-06-15 1998-06-15 Mycobacterial inhibitors
PCT/SE1999/000732 WO1999065483A1 (en) 1998-05-05 1999-05-03 Mycobacterial inhibitors

Publications (1)

Publication Number Publication Date
IL139144A0 true IL139144A0 (en) 2001-11-25

Family

ID=26324850

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13914499A IL139144A0 (en) 1998-05-05 1999-05-03 Mycobacterial inhibitors

Country Status (14)

Country Link
US (1) US6476053B1 (https=)
EP (1) EP1075261B1 (https=)
JP (1) JP2002518324A (https=)
KR (1) KR20010043322A (https=)
CN (1) CN1201735C (https=)
AT (1) ATE322898T1 (https=)
AU (1) AU739140B2 (https=)
BR (1) BR9910185A (https=)
CA (1) CA2330667A1 (https=)
DE (1) DE69930844T2 (https=)
IL (1) IL139144A0 (https=)
NO (1) NO20005548L (https=)
NZ (1) NZ507620A (https=)
WO (1) WO1999065483A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002350115A1 (en) 2001-11-01 2003-05-12 Spectrum Pharmaceuticals, Inc. Medical compositions for intravesical treatment of bladder cancer
KR20080034944A (ko) * 2005-08-19 2008-04-22 아스트라제네카 아베 결핵 치료용 피라졸론 유도체
GB0520368D0 (en) * 2005-10-06 2005-11-16 Univ Aston Antibacterial pyrrols
EP2373617B1 (de) 2008-12-04 2015-02-25 Basf Se Mischungen aus itaconsäure oder itaconsäurederivaten und primären aminen zur herstellung von 1,3- und 1,4-alkylmethylpyrrolidonen
CA3009323C (en) * 2015-12-23 2023-01-24 Henkel Ag & Co. Kgaa Metal working fluid
CN107033060B (zh) * 2017-05-04 2020-01-14 浙江工业大学 一种n-取代顺丁烯二酰亚胺类化合物及其制备与抗菌应用
CN111465611B (zh) * 2017-12-01 2024-10-11 古德T细胞有限公司 预防或治疗脱发的组合物
CN119569636B (zh) * 2024-10-22 2026-03-27 南京吉星生物技术开发有限公司 一种吡咯啉二酮类化合物及其制备方法和杀菌剂应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883342A (en) * 1973-04-13 1975-05-13 Akzona Inc Plant growth regulators

Also Published As

Publication number Publication date
NO20005548L (no) 2000-12-04
EP1075261A1 (en) 2001-02-14
CN1201735C (zh) 2005-05-18
JP2002518324A (ja) 2002-06-25
NO20005548D0 (no) 2000-11-03
DE69930844D1 (de) 2006-05-24
DE69930844T2 (de) 2006-12-28
CA2330667A1 (en) 1999-12-23
ATE322898T1 (de) 2006-04-15
BR9910185A (pt) 2001-01-09
EP1075261B1 (en) 2006-04-12
US6476053B1 (en) 2002-11-05
AU739140B2 (en) 2001-10-04
WO1999065483A1 (en) 1999-12-23
KR20010043322A (ko) 2001-05-25
NZ507620A (en) 2003-05-30
CN1308532A (zh) 2001-08-15
AU4304199A (en) 2000-01-05

Similar Documents

Publication Publication Date Title
AP9901534A0 (en) Pharmaceutical formulations.
DE69905170D1 (en) Thiazolopyrimidinderivate
AP9901514A0 (en) Pyrazolopyrimidinone cgmp PDE5 inhibitors for the treatment of sexual disfunction
YU15299A (sh) Farmaceutski sastavi
WO2001044247A3 (en) Agents and methods for the treatment of proliferative diseases
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
BG105270A (en) Tetrahydropyridoethers
MY138285A (en) Fab i inhibitors
AU3831301A (en) Method for treating ocular pain
AU2002248269A1 (en) Use of p38 inhibitors for the treatment of inflammation-enhanced cough
YU13301A (sh) Muskarinski agonisti i antagonisti
AU2001260880A1 (en) Pharmaceutical compounds for treating copd
GB9804886D0 (en) Therapeutic combination
SE9802937D0 (sv) Novel compounds
CU23088A3 (es) Compuestos de tetra-hidropiridina.
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
GB9907571D0 (en) Compounds
IL139144A0 (en) Mycobacterial inhibitors
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
MXPA02011558A (es) Inhibidores de mmp-2/mp-9 novedosos.
AU2576901A (en) Agents and methods for the treatment of proliferative diseases
ZA9711468B (en) New use of comt inhibitors
MXPA03010451A (es) Nuevos metodos para el tratamiento y prevencion del dolor.
PT1042288E (pt) Inibidores de tripeptidil peptidase